Versant Ventures VI GP-GP, LLC
Insider CIK 1777652 · TPST 10% owner · OYST 10% owner · AKRO 10% owner · PASG 10% owner · PAND 10% owner · RPTX 10% owner · GRPH 10% owner · GLUE 10% owner · LVTX 10% owner · IPSC 10% owner · CTNM 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-09-30 | 2025-10-02 | 123 | $47.01 | $5.8K | 764,127 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-09-30 | 2025-10-02 | 177 | $47.01 | $8.3K | 1,050,599 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-09-30 | 2025-10-02 | 57,502 | $46.41 | $2.67M | 764,250 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-09-30 | 2025-10-02 | 83,066 | $46.41 | $3.86M | 1,050,776 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-09-30 | 2025-10-02 | 49,701 | $45.35 | $2.25M | 1,133,842 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-09-30 | 2025-10-02 | 34,405 | $45.35 | $1.56M | 821,752 | SEC↗ |
| LVTX LAVA Therapeutics NV | S Sale | 2025-09-19 | 2025-09-23 | 532,870 | $1.40 | $746.0K | 0 | SEC↗ |
| LVTX LAVA Therapeutics NV | S Sale | 2025-09-19 | 2025-09-23 | 2,370,533 | $1.40 | $3.32M | 0 | SEC↗ |
| LVTX LAVA Therapeutics NV | S Sale | 2025-09-18 | 2025-09-18 | 228,791 | $1.44 | $329.5K | 532,870 | SEC↗ |
| LVTX LAVA Therapeutics NV | S Sale | 2025-09-18 | 2025-09-18 | 366,111 | $1.44 | $527.2K | 2,370,533 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-09-18 | 2025-09-22 | 40,907 | $43.00 | $1.76M | 1,183,811 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-09-18 | 2025-09-22 | 268 | $43.30 | $11.6K | 1,183,543 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-09-18 | 2025-09-22 | 20,148 | $43.00 | $866.4K | 856,289 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-09-18 | 2025-09-22 | 132 | $43.30 | $5.7K | 856,157 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-09-18 | 2025-09-22 | 24,370 | $41.59 | $1.01M | 876,437 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-09-18 | 2025-09-22 | 49,479 | $41.59 | $2.06M | 1,224,718 | SEC↗ |
| LVTX LAVA Therapeutics NV | S Sale | 2025-09-17 | 2025-09-18 | 226,726 | $1.49 | $337.8K | 761,661 | SEC↗ |
| LVTX LAVA Therapeutics NV | S Sale | 2025-09-17 | 2025-09-18 | 362,806 | $1.49 | $540.6K | 2,736,644 | SEC↗ |
| LVTX LAVA Therapeutics NV | S Sale | 2025-09-16 | 2025-09-18 | 192,293 | $1.53 | $294.2K | 988,387 | SEC↗ |
| LVTX LAVA Therapeutics NV | S Sale | 2025-09-16 | 2025-09-18 | 307,707 | $1.53 | $470.8K | 3,099,450 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-08-26 | 2025-08-26 | 21,661 | $38.97 | $844.1K | 902,514 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-08-26 | 2025-08-26 | 3,465 | $39.50 | $136.9K | 1,274,197 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-08-26 | 2025-08-26 | 1,707 | $39.50 | $67.4K | 900,807 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-08-26 | 2025-08-26 | 43,978 | $38.97 | $1.71M | 1,277,662 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-08-25 | 2025-08-26 | 2,149 | $39.92 | $85.8K | 1,321,640 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-08-25 | 2025-08-26 | 24,760 | $39.53 | $978.8K | 925,233 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-08-25 | 2025-08-26 | 50,270 | $39.53 | $1.99M | 1,323,789 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-08-25 | 2025-08-26 | 1,058 | $39.92 | $42.2K | 924,175 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-08-22 | 2025-08-26 | 10,076 | $40.03 | $403.3K | 952,802 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-08-22 | 2025-08-26 | 2,809 | $40.59 | $114.0K | 949,993 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-08-22 | 2025-08-26 | 5,668 | $40.59 | $230.1K | 1,374,059 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-08-22 | 2025-08-26 | 20,493 | $40.03 | $820.3K | 1,379,727 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-08-18 | 2025-08-19 | 30,628 | $38.56 | $1.18M | 1,400,220 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-08-18 | 2025-08-19 | 15,085 | $38.56 | $581.7K | 962,878 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-08-15 | 2025-08-19 | 145,051 | $39.50 | $5.73M | 1,430,848 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-08-15 | 2025-08-19 | 69,949 | $39.50 | $2.76M | 977,963 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-07-10 | 2025-07-14 | 191,376 | $34.00 | $6.51M | 1,575,899 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-06-27 | 2025-07-01 | 200,000 | $30.47 | $6.09M | 1,767,275 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-06-20 | 2025-06-20 | 133,924 | $30.25 | $4.05M | 1,967,275 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-06-20 | 2025-06-20 | 100,877 | $30.35 | $3.06M | 1,047,912 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-06-18 | 2025-06-20 | 100,000 | $29.95 | $3.00M | 1,148,789 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-06-10 | 2025-06-12 | 350,000 | $29.00 | $10.15M | 1,248,789 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | S Sale | 2024-10-29 | 2024-10-30 | 52,305 | $9.08 | $474.9K | 1,589,053 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | S Sale | 2024-10-29 | 2024-10-30 | 15,600 | $9.41 | $146.8K | 1,573,453 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | J Other | 2024-10-28 | 2024-10-30 | 366,590 | — | $0 | 1,641,358 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | J Other | 2024-10-28 | 2024-10-30 | 5,454 | — | $0 | 0 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | J Other | 2024-10-28 | 2024-10-30 | 5,454 | — | $0 | 5,454 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | J Other | 2024-10-28 | 2024-10-30 | 5,499 | — | $0 | 0 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | J Other | 2024-10-28 | 2024-10-30 | 5,499 | — | $0 | 5,499 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | J Other | 2024-10-28 | 2024-10-30 | 17,595 | — | $0 | 0 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | J Other | 2024-10-28 | 2024-10-30 | 17,595 | — | $0 | 17,595 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | J Other | 2024-10-28 | 2024-10-30 | 20,397 | — | $0 | 0 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | J Other | 2024-10-28 | 2024-10-30 | 20,397 | — | $0 | 20,397 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | J Other | 2024-10-28 | 2024-10-30 | 1,019,867 | — | $0 | 4,079,469 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | S Sale | 2024-10-28 | 2024-10-30 | 89,990 | $9.66 | $869.3K | 2,007,948 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | S Sale | 2024-09-20 | 2024-09-24 | 1,132,566 | $6.53 | $7.40M | 5,099,336 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | S Sale | 2024-09-13 | 2024-09-13 | 9,269 | $6.16 | $57.1K | 6,231,902 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | S Sale | 2024-09-12 | 2024-09-13 | 16,047 | $6.00 | $96.3K | 6,241,171 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | S Sale | 2024-09-11 | 2024-09-13 | 541,897 | $6.00 | $3.25M | 6,257,218 | SEC↗ |
| TPST Tempest Therapeutics, Inc. | S Sale | 2024-08-12 | 2024-08-12 | 387,999 | $1.10 | $426.8K | 209,941 | SEC↗ |
| TPST Tempest Therapeutics, Inc. | S Sale | 2024-08-08 | 2024-08-12 | 400,000 | $1.35 | $540.0K | 597,940 | SEC↗ |
| CTNM Contineum Therapeutics, In | C Conversion deriv | 2024-04-09 | 2024-04-11 | 455 | — | $0 | 0 | SEC↗ |
| CTNM Contineum Therapeutics, In | C Conversion deriv | 2024-04-09 | 2024-04-11 | 70,498 | — | $0 | 0 | SEC↗ |
| CTNM Contineum Therapeutics, In | C Conversion deriv | 2024-04-09 | 2024-04-11 | 298,975 | — | $0 | 0 | SEC↗ |
| CTNM Contineum Therapeutics, In | C Conversion deriv | 2024-04-09 | 2024-04-11 | 1,931 | — | $0 | 0 | SEC↗ |
| CTNM Contineum Therapeutics, In | C Conversion deriv | 2024-04-09 | 2024-04-11 | 275,769 | — | $0 | 710,494 | SEC↗ |
| CTNM Contineum Therapeutics, In | C Conversion deriv | 2024-04-09 | 2024-04-11 | 689 | — | $0 | 12,123 | SEC↗ |
| CTNM Contineum Therapeutics, In | C Conversion deriv | 2024-04-09 | 2024-04-11 | 110,187 | — | $0 | 1,934,776 | SEC↗ |
| CTNM Contineum Therapeutics, In | C Conversion deriv | 2024-04-09 | 2024-04-11 | 317,988 | — | $0 | 1,741,107 | SEC↗ |
| CTNM Contineum Therapeutics, In | C Conversion deriv | 2024-04-09 | 2024-04-11 | 434,725 | — | $0 | 434,725 | SEC↗ |
| CTNM Contineum Therapeutics, In | C Conversion deriv | 2024-04-09 | 2024-04-11 | 2,182 | — | $0 | 11,434 | SEC↗ |
| CTNM Contineum Therapeutics, In | C Conversion deriv | 2024-04-09 | 2024-04-11 | 348,143 | — | $0 | 1,824,589 | SEC↗ |
| CTNM Contineum Therapeutics, In | C Conversion deriv | 2024-04-09 | 2024-04-11 | 1,423,119 | — | $0 | 1,423,119 | SEC↗ |
| CTNM Contineum Therapeutics, In | C Conversion deriv | 2024-04-09 | 2024-04-11 | 9,252 | — | $0 | 9,252 | SEC↗ |
| CTNM Contineum Therapeutics, In | C Conversion deriv | 2024-04-09 | 2024-04-11 | 1,476,446 | — | $0 | 1,476,446 | SEC↗ |
| CTNM Contineum Therapeutics, In | C Conversion deriv | 2024-04-09 | 2024-04-11 | 57,565 | — | $0 | 0 | SEC↗ |
| CTNM Contineum Therapeutics, In | C Conversion deriv | 2024-04-09 | 2024-04-11 | 145 | — | $0 | 0 | SEC↗ |
| CTNM Contineum Therapeutics, In | C Conversion deriv | 2024-04-09 | 2024-04-11 | 22,312 | — | $0 | 0 | SEC↗ |
| CTNM Contineum Therapeutics, In | C Conversion deriv | 2024-04-09 | 2024-04-11 | 90,747 | — | $0 | 0 | SEC↗ |
| CTNM Contineum Therapeutics, In | C Conversion | 2024-04-09 | 2024-04-11 | 2,531 | — | $0 | 2,531 | SEC↗ |
| CTNM Contineum Therapeutics, In | C Conversion | 2024-04-09 | 2024-04-11 | 148,312 | — | $0 | 148,312 | SEC↗ |
| CTNM Contineum Therapeutics, In | C Conversion | 2024-04-09 | 2024-04-11 | 391,785 | — | $0 | 391,785 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | J Other | 2024-03-21 | 2024-03-25 | 598,203 | — | $0 | 842,162 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | U Tender | 2023-01-03 | 2023-01-04 | 1,003,658 | — | $0 | 0 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | U Tender | 2023-01-03 | 2023-01-04 | 2,236,888 | — | $0 | 0 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | U Tender | 2023-01-03 | 2023-01-04 | 414,607 | — | $0 | 0 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | U Tender | 2023-01-03 | 2023-01-04 | 2,465 | — | $0 | 0 | SEC↗ |
| IPSC Century Therapeutics, Inc. | S Sale | 2022-08-09 | 2022-08-11 | 550,000 | $13.03 | $7.17M | 11,816,814 | SEC↗ |
| IPSC Century Therapeutics, Inc. | J Other | 2022-08-09 | 2022-08-11 | 364,800 | — | $0 | 11,452,014 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2022-06-06 | 2022-06-07 | 614,315 | — | $0 | 850,560 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2022-06-06 | 2022-06-07 | 10,099 | — | $0 | 0 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2022-06-06 | 2022-06-07 | 10,099 | — | $0 | 10,099 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2022-06-06 | 2022-06-07 | 46,753 | — | $0 | 64,731 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2022-06-06 | 2022-06-07 | 141,103 | — | $0 | 0 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2022-06-06 | 2022-06-07 | 4,419 | — | $0 | 141,103 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2022-06-06 | 2022-06-07 | 20,454 | — | $0 | 28,322 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2022-06-06 | 2022-06-07 | 3,992 | — | $0 | 136,684 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2022-06-06 | 2022-06-07 | 18,478 | — | $0 | 25,587 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2022-06-06 | 2022-06-07 | 132,692 | — | $0 | 132,692 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2022-06-03 | 2022-06-07 | 250,000 | $12.25 | $3.06M | 2,344,451 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2022-06-03 | 2022-06-07 | 438,795 | $12.25 | $5.38M | 1,464,875 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2022-06-03 | 2022-06-07 | 13,199 | $12.25 | $161.7K | 44,065 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2022-06-03 | 2022-06-07 | 33,395 | $12.25 | $409.1K | 111,484 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2022-06-03 | 2022-06-07 | 14,611 | $12.25 | $179.0K | 48,776 | SEC↗ |
| IPSC Century Therapeutics, Inc. | J Other | 2022-01-31 | 2022-02-02 | 178,996 | — | $0 | 12,366,814 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2022-01-05 | 2022-01-07 | 1,261 | — | $0 | 2,465 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2022-01-05 | 2022-01-07 | 200,213 | — | $0 | 414,607 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2022-01-05 | 2022-01-07 | 51,556 | — | $0 | 51,556 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2022-01-05 | 2022-01-07 | 51,556 | — | $0 | 0 | SEC↗ |
| IPSC Century Therapeutics, Inc. | J Other | 2021-12-23 | 2021-12-28 | 371,004 | — | $0 | 12,545,810 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2021-12-21 | 2021-12-23 | 51,556 | — | $0 | 51,556 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2021-12-21 | 2021-12-23 | 1,261 | — | $0 | 3,726 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2021-12-21 | 2021-12-23 | 51,556 | — | $0 | 0 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2021-12-21 | 2021-12-23 | 200,213 | — | $0 | 614,820 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | S Sale | 2021-10-18 | 2021-10-20 | 1,912 | $14.63 | $28.0K | 6,518 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | S Sale | 2021-10-18 | 2021-10-20 | 242,943 | $15.09 | $3.67M | 815,033 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | S Sale | 2021-10-18 | 2021-10-20 | 1,531 | $15.09 | $23.1K | 4,987 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | S Sale | 2021-10-18 | 2021-10-20 | 303,614 | $14.63 | $4.44M | 1,057,976 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-08-05 | 2021-08-09 | 152,071 | — | $0 | 231,211 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-08-05 | 2021-08-09 | 2,260 | — | $0 | 0 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-08-05 | 2021-08-09 | 2,260 | — | $0 | 2,260 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-08-05 | 2021-08-09 | 2,279 | — | $0 | 0 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-08-05 | 2021-08-09 | 2,279 | — | $0 | 2,279 | SEC↗ |
| GRPH Graphite Bio, Inc. | C Conversion deriv | 2021-06-29 | 2021-07-01 | 3,715,415 | — | $0 | 0 | SEC↗ |
| GRPH Graphite Bio, Inc. | C Conversion deriv | 2021-06-29 | 2021-07-01 | 30,019,945 | — | $0 | 0 | SEC↗ |
| GRPH Graphite Bio, Inc. | C Conversion | 2021-06-29 | 2021-07-01 | 12,343,727 | — | $0 | 14,708,398 | SEC↗ |
| GRPH Graphite Bio, Inc. | C Conversion | 2021-06-29 | 2021-07-01 | 1,527,719 | — | $0 | 1,527,719 | SEC↗ |
| GRPH Graphite Bio, Inc. | P Buy | 2021-06-29 | 2021-07-01 | 180,000 | $17.00 | $3.06M | 1,707,719 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | C Conversion deriv | 2021-06-28 | 2021-06-30 | 3,000,000 | — | $0 | 0 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | C Conversion deriv | 2021-06-28 | 2021-06-30 | 20,004,280 | — | $0 | 0 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | C Conversion deriv | 2021-06-28 | 2021-06-30 | 4,150,000 | — | $0 | 0 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | C Conversion deriv | 2021-06-28 | 2021-06-30 | 2,699,328 | — | $0 | 0 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | P Buy | 2021-06-28 | 2021-06-30 | 157,895 | $19.00 | $3.00M | 2,097,938 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | C Conversion | 2021-06-28 | 2021-06-30 | 6,515,869 | — | $0 | 6,799,115 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | C Conversion | 2021-06-28 | 2021-06-30 | 1,940,043 | — | $0 | 1,940,043 | SEC↗ |
| IPSC Century Therapeutics, Inc. | C Conversion deriv | 2021-06-22 | 2021-06-23 | 25,000,000 | — | $0 | 0 | SEC↗ |
| IPSC Century Therapeutics, Inc. | C Conversion deriv | 2021-06-22 | 2021-06-23 | 1,545,125 | — | $0 | 0 | SEC↗ |
| IPSC Century Therapeutics, Inc. | P Buy | 2021-06-22 | 2021-06-23 | 100,000 | $20.00 | $2.00M | 714,095 | SEC↗ |
| IPSC Century Therapeutics, Inc. | C Conversion | 2021-06-22 | 2021-06-23 | 614,095 | — | $0 | 614,095 | SEC↗ |
| IPSC Century Therapeutics, Inc. | C Conversion | 2021-06-22 | 2021-06-23 | 9,936,011 | — | $0 | 12,916,814 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-06-01 | 2021-06-03 | 1,119 | — | $0 | 1,119 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-06-01 | 2021-06-03 | 1,128 | — | $0 | 1,128 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-06-01 | 2021-06-03 | 75,000 | — | $0 | 383,282 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-06-01 | 2021-06-03 | 1,119 | — | $0 | 0 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-06-01 | 2021-06-03 | 1,128 | — | $0 | 0 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2021-05-12 | 2021-05-14 | 320,340 | — | $0 | 1,361,590 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2021-05-12 | 2021-05-14 | 82,486 | — | $0 | 0 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2021-05-12 | 2021-05-14 | 2,018 | — | $0 | 8,430 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2021-05-12 | 2021-05-14 | 82,486 | — | $0 | 82,486 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-05-05 | 2021-05-07 | 6,355 | — | $0 | 57,264 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-05-05 | 2021-05-07 | 3,473 | — | $0 | 3,473 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-05-05 | 2021-05-07 | 16,079 | — | $0 | 144,879 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-05-05 | 2021-05-07 | 211,277 | — | $0 | 1,903,670 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-05-05 | 2021-05-07 | 45,635 | — | $0 | 45,635 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-05-05 | 2021-05-07 | 3,473 | — | $0 | 0 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-05-05 | 2021-05-07 | 1,373 | — | $0 | 47,008 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-05-05 | 2021-05-07 | 7,035 | — | $0 | 63,387 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-05-05 | 2021-05-07 | 1,520 | — | $0 | 48,528 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-05-05 | 2021-05-07 | 48,528 | — | $0 | 0 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2021-03-26 | 2021-03-30 | 1,990 | — | $0 | 10,448 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2021-03-26 | 2021-03-30 | 82,491 | — | $0 | 0 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2021-03-26 | 2021-03-30 | 82,491 | — | $0 | 82,491 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2021-03-26 | 2021-03-30 | 320,368 | — | $0 | 1,681,930 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2021-02-17 | 2021-02-19 | 5,607 | — | $0 | 0 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2021-02-17 | 2021-02-19 | 325,000 | — | $0 | 2,236,888 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2021-02-17 | 2021-02-19 | 6,500 | — | $0 | 6,500 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2021-02-17 | 2021-02-19 | 6,500 | — | $0 | 0 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2021-02-17 | 2021-02-19 | 5,607 | — | $0 | 5,607 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-02-16 | 2021-02-18 | 751 | — | $0 | 751 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-02-16 | 2021-02-18 | 745 | — | $0 | 0 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-02-16 | 2021-02-18 | 745 | — | $0 | 745 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-02-16 | 2021-02-18 | 751 | — | $0 | 0 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-02-16 | 2021-02-18 | 300,000 | — | $0 | 2,594,451 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-02-16 | 2021-02-18 | 6,000 | — | $0 | 6,000 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-02-16 | 2021-02-18 | 6,000 | — | $0 | 0 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-02-16 | 2021-02-18 | 5,176 | — | $0 | 5,176 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-02-16 | 2021-02-18 | 5,176 | — | $0 | 0 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-02-16 | 2021-02-18 | 50,000 | — | $0 | 458,282 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-01-29 | 2021-02-02 | 4,328 | — | $0 | 4,328 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-01-29 | 2021-02-02 | 263,278 | — | $0 | 2,114,947 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-01-29 | 2021-02-02 | 56,868 | — | $0 | 56,868 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-01-29 | 2021-02-02 | 7,919 | — | $0 | 63,619 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-01-29 | 2021-02-02 | 745 | — | $0 | 745 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-01-29 | 2021-02-02 | 751 | — | $0 | 0 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-01-29 | 2021-02-02 | 751 | — | $0 | 751 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-01-29 | 2021-02-02 | 50,000 | — | $0 | 508,282 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-01-29 | 2021-02-02 | 4,313 | — | $0 | 0 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-01-29 | 2021-02-02 | 4,313 | — | $0 | 4,313 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-01-29 | 2021-02-02 | 5,000 | — | $0 | 0 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-01-29 | 2021-02-02 | 5,000 | — | $0 | 5,000 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-01-29 | 2021-02-02 | 250,000 | — | $0 | 2,894,451 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-01-29 | 2021-02-02 | 4,328 | — | $0 | 0 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-01-29 | 2021-02-02 | 745 | — | $0 | 0 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-01-29 | 2021-02-02 | 20,037 | — | $0 | 160,958 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-01-29 | 2021-02-02 | 60,472 | — | $0 | 0 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-01-29 | 2021-02-02 | 1,893 | — | $0 | 60,472 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-01-29 | 2021-02-02 | 8,766 | — | $0 | 70,422 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-01-29 | 2021-02-02 | 1,711 | — | $0 | 58,579 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-01-14 | 2021-01-19 | 745 | — | $0 | 745 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-01-14 | 2021-01-19 | 50,000 | — | $0 | 558,282 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-01-14 | 2021-01-19 | 4,744 | — | $0 | 0 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-01-14 | 2021-01-19 | 4,744 | — | $0 | 4,744 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-01-14 | 2021-01-19 | 5,500 | — | $0 | 0 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-01-14 | 2021-01-19 | 5,500 | — | $0 | 5,500 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-01-14 | 2021-01-19 | 275,000 | — | $0 | 3,144,451 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-01-14 | 2021-01-19 | 1,388 | — | $0 | 0 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-01-14 | 2021-01-19 | 1,388 | — | $0 | 1,388 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-01-14 | 2021-01-19 | 11,688 | — | $0 | 180,995 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-01-14 | 2021-01-19 | 35,276 | — | $0 | 0 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-01-14 | 2021-01-19 | 1,105 | — | $0 | 35,276 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-01-14 | 2021-01-19 | 5,113 | — | $0 | 79,188 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-01-14 | 2021-01-19 | 998 | — | $0 | 34,171 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-01-14 | 2021-01-19 | 4,620 | — | $0 | 71,538 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-01-14 | 2021-01-19 | 33,173 | — | $0 | 33,173 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-01-14 | 2021-01-19 | 153,579 | — | $0 | 2,378,225 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-01-14 | 2021-01-19 | 751 | — | $0 | 0 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-01-14 | 2021-01-19 | 751 | — | $0 | 751 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-01-14 | 2021-01-19 | 745 | — | $0 | 0 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2020-12-15 | 2020-12-17 | 21,707 | — | $0 | 192,683 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2020-12-15 | 2020-12-17 | 9,497 | — | $0 | 84,301 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2020-12-15 | 2020-12-17 | 8,579 | — | $0 | 76,158 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2020-12-15 | 2020-12-17 | 285,217 | — | $0 | 2,531,804 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | C Conversion deriv | 2020-07-21 | 2020-07-21 | 333,333 | — | $0 | 0 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | C Conversion deriv | 2020-07-21 | 2020-07-21 | 14,452,795 | — | $0 | 0 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | C Conversion deriv | 2020-07-21 | 2020-07-21 | 1,745,458 | — | $0 | 0 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | C Conversion deriv | 2020-07-21 | 2020-07-21 | 1,245,330 | — | $0 | 0 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | C Conversion | 2020-07-21 | 2020-07-21 | 3,176,507 | — | $0 | 3,176,507 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | C Conversion | 2020-07-21 | 2020-07-21 | 577,544 | — | $0 | 577,544 | SEC↗ |
| RPTX Repare Therapeutics Inc. | C Conversion deriv | 2020-06-23 | 2020-06-25 | 8,475 | — | $0 | 0 | SEC↗ |
| RPTX Repare Therapeutics Inc. | C Conversion deriv | 2020-06-23 | 2020-06-25 | 2,054,198 | — | $0 | 0 | SEC↗ |
| RPTX Repare Therapeutics Inc. | C Conversion deriv | 2020-06-23 | 2020-06-25 | 156,335 | — | $0 | 0 | SEC↗ |
| RPTX Repare Therapeutics Inc. | C Conversion deriv | 2020-06-23 | 2020-06-25 | 68,398 | — | $0 | 0 | SEC↗ |
| RPTX Repare Therapeutics Inc. | C Conversion deriv | 2020-06-23 | 2020-06-25 | 61,791 | — | $0 | 0 | SEC↗ |
| RPTX Repare Therapeutics Inc. | C Conversion deriv | 2020-06-23 | 2020-06-25 | 2,443,883 | — | $0 | 0 | SEC↗ |
| RPTX Repare Therapeutics Inc. | C Conversion deriv | 2020-06-23 | 2020-06-25 | 111,361 | — | $0 | 0 | SEC↗ |
| RPTX Repare Therapeutics Inc. | C Conversion deriv | 2020-06-23 | 2020-06-25 | 3,708 | — | $0 | 0 | SEC↗ |
| RPTX Repare Therapeutics Inc. | C Conversion deriv | 2020-06-23 | 2020-06-25 | 3,350 | — | $0 | 0 | SEC↗ |
| RPTX Repare Therapeutics Inc. | C Conversion deriv | 2020-06-23 | 2020-06-25 | 875,568 | — | $0 | 0 | SEC↗ |
| RPTX Repare Therapeutics Inc. | C Conversion deriv | 2020-06-23 | 2020-06-25 | 458,282 | — | $0 | 0 | SEC↗ |
| RPTX Repare Therapeutics Inc. | C Conversion | 2020-06-23 | 2020-06-25 | 458,282 | — | $0 | 458,282 | SEC↗ |
| RPTX Repare Therapeutics Inc. | C Conversion | 2020-06-23 | 2020-06-25 | 68,398 | — | $0 | 90,090 | SEC↗ |
| RPTX Repare Therapeutics Inc. | C Conversion | 2020-06-23 | 2020-06-25 | 156,335 | — | $0 | 205,915 | SEC↗ |
| RPTX Repare Therapeutics Inc. | C Conversion | 2020-06-23 | 2020-06-25 | 2,054,198 | — | $0 | 2,705,660 | SEC↗ |
| RPTX Repare Therapeutics Inc. | P Buy | 2020-06-23 | 2020-06-25 | 100,000 | $20.00 | $2.00M | 3,419,451 | SEC↗ |
| RPTX Repare Therapeutics Inc. | P Buy | 2020-06-23 | 2020-06-25 | 150,000 | $20.00 | $3.00M | 608,282 | SEC↗ |
| RPTX Repare Therapeutics Inc. | C Conversion | 2020-06-23 | 2020-06-25 | 61,791 | — | $0 | 81,387 | SEC↗ |
| RPTX Repare Therapeutics Inc. | C Conversion | 2020-06-23 | 2020-06-25 | 875,568 | — | $0 | 3,319,451 | SEC↗ |
| RPTX Repare Therapeutics Inc. | C Conversion | 2020-06-23 | 2020-06-25 | 3,350 | — | $0 | 84,737 | SEC↗ |
| RPTX Repare Therapeutics Inc. | C Conversion | 2020-06-23 | 2020-06-25 | 3,708 | — | $0 | 93,798 | SEC↗ |
| RPTX Repare Therapeutics Inc. | C Conversion | 2020-06-23 | 2020-06-25 | 8,475 | — | $0 | 214,390 | SEC↗ |
| RPTX Repare Therapeutics Inc. | C Conversion | 2020-06-23 | 2020-06-25 | 111,361 | — | $0 | 2,817,021 | SEC↗ |
| RPTX Repare Therapeutics Inc. | C Conversion | 2020-06-23 | 2020-06-25 | 2,443,883 | — | $0 | 2,443,883 | SEC↗ |
| PASG Passage BIO, Inc. | C Conversion deriv | 2020-03-03 | 2020-03-03 | 1,049,175 | — | $0 | 0 | SEC↗ |
| PASG Passage BIO, Inc. | C Conversion deriv | 2020-03-03 | 2020-03-03 | 708,352 | — | $0 | 0 | SEC↗ |
| PASG Passage BIO, Inc. | C Conversion deriv | 2020-03-03 | 2020-03-03 | 2,977,242 | — | $0 | 0 | SEC↗ |
| PASG Passage BIO, Inc. | C Conversion | 2020-03-03 | 2020-03-03 | 1,049,175 | — | $0 | 4,026,417 | SEC↗ |
| PASG Passage BIO, Inc. | C Conversion | 2020-03-03 | 2020-03-03 | 708,352 | — | $0 | 708,352 | SEC↗ |
| PASG Passage BIO, Inc. | P Buy | 2020-03-03 | 2020-03-03 | 225,000 | $18.00 | $4.05M | 933,352 | SEC↗ |
| PASG Passage BIO, Inc. | C Conversion | 2020-03-03 | 2020-03-03 | 2,977,242 | — | $0 | 2,977,242 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-01-21 | 2020-01-21 | 8,091 | $21.78 | $176.2K | 3,110,547 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-01-21 | 2020-01-21 | 17,849 | $22.39 | $399.6K | 3,092,698 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-01-17 | 2020-01-21 | 11,103 | $20.09 | $223.1K | 3,118,638 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-01-16 | 2020-01-21 | 22,489 | $19.72 | $443.5K | 3,129,741 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-01-15 | 2020-01-15 | 7,511 | $19.73 | $148.2K | 3,152,230 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-01-14 | 2020-01-15 | 12,307 | $20.00 | $246.1K | 3,159,741 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-01-13 | 2020-01-15 | 83 | $20.84 | $1.7K | 3,172,048 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-01-13 | 2020-01-15 | 11,593 | $20.16 | $233.7K | 3,172,131 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-01-10 | 2020-01-15 | 19,343 | $20.10 | $388.8K | 3,183,724 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-01-09 | 2020-07-10 | 16,527 | $20.21 | $334.0K | 2,846,941 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-01-09 | 2020-01-09 | 16,527 | $20.21 | $334.0K | 3,203,067 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-01-08 | 2020-07-10 | 22,368 | $19.80 | $442.9K | 2,863,468 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-01-08 | 2020-01-09 | 22,368 | $19.80 | $442.9K | 3,219,594 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-01-07 | 2020-07-10 | 14,162 | $20.05 | $283.9K | 2,885,836 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-01-07 | 2020-01-09 | 14,162 | $20.05 | $283.9K | 3,241,962 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-01-06 | 2020-07-10 | 4,968 | $17.68 | $87.8K | 2,948,422 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-01-06 | 2020-07-10 | 6,101 | $18.32 | $111.8K | 2,942,321 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-01-06 | 2020-07-10 | 42,323 | $19.93 | $843.5K | 2,899,998 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-01-06 | 2020-01-06 | 4,968 | $17.68 | $87.8K | 3,304,548 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-01-06 | 2020-01-06 | 6,101 | $18.32 | $111.8K | 3,298,447 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-01-06 | 2020-01-06 | 42,323 | $19.93 | $843.5K | 3,256,124 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-01-03 | 2020-07-10 | 3,100 | $19.18 | $59.5K | 2,953,490 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-01-03 | 2020-07-10 | 100 | $20.27 | $2.0K | 2,953,390 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-01-03 | 2020-01-06 | 100 | $20.27 | $2.0K | 3,309,516 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-01-03 | 2020-01-06 | 3,100 | $19.18 | $59.5K | 3,309,616 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-01-02 | 2020-07-10 | 10,952 | $19.89 | $217.8K | 3,645,633 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-01-02 | 2020-07-10 | 3,900 | $21.20 | $82.7K | 3,641,733 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-01-02 | 2020-07-10 | 1,000 | $22.17 | $22.2K | 3,640,733 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | J Other | 2020-01-02 | 2020-07-10 | 684,143 | — | $0 | 2,956,590 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | J Other | 2020-01-02 | 2020-07-10 | 13,683 | — | $0 | 13,683 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | J Other | 2020-01-02 | 2020-07-10 | 13,683 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | J Other | 2020-01-02 | 2020-07-10 | 11,803 | — | $0 | 11,803 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | J Other | 2020-01-02 | 2020-07-10 | 11,803 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | J Other | 2020-01-02 | 2020-01-06 | 11,803 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-01-02 | 2020-01-06 | 10,952 | $19.89 | $217.8K | 4,001,759 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | J Other | 2020-01-02 | 2020-01-06 | 11,803 | — | $0 | 11,803 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | J Other | 2020-01-02 | 2020-01-06 | 13,683 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | J Other | 2020-01-02 | 2020-01-06 | 13,683 | — | $0 | 13,683 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | J Other | 2020-01-02 | 2020-01-06 | 684,143 | — | $0 | 3,312,716 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-01-02 | 2020-01-06 | 1,000 | $22.17 | $22.2K | 3,996,859 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-01-02 | 2020-01-06 | 3,900 | $21.20 | $82.7K | 3,997,859 | SEC↗ |